<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Torres Robinson | Activity</title>
	<link>https://www.catswannabecats.com/members/tripnight52/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/tripnight52/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Torres Robinson.</description>
	<lastBuildDate>Wed, 24 Jun 2026 08:20:47 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">3365e279d14d55900539db23626d3aa9</guid>
				<title>Torres Robinson posted an update: RESULTS CCS uptake remained relatively stable over time, [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/25568/</link>
				<pubDate>Mon, 09 Jun 2025 11:06:08 -0400</pubDate>

									<content:encoded><![CDATA[<p>RESULTS CCS uptake remained relatively stable over time, with a mean coverage of 70.9% in Belgium and 73.1% in Switzerland. Educational and income gradients were found in both countries. Concerning CCS overuse, women above screening-eligible age showed consistently high screening rates, but screening within the past year declined significantly in&hellip;<span class="activity-read-more" id="activity-read-more-25568"><a href="https://www.catswannabecats.com/activity/p/25568/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">75264951449697a7711870262712ed49</guid>
				<title>Torres Robinson posted an update: The combined technique achieved a good scar quality and [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/23929/</link>
				<pubDate>Sun, 08 Jun 2025 10:56:25 -0400</pubDate>

									<content:encoded><![CDATA[<p>The combined technique achieved a good scar quality and aesthetic effect on burned hands as well as excellent functional outcome, which resulted in major improvements and an independent life for the patient.</p>
<p> Astragaloside IV (AS-IV) is a natural herb extract and a popular compound used in traditional Chinese medicine because of its effect on&hellip;<span class="activity-read-more" id="activity-read-more-23929"><a href="https://www.catswannabecats.com/activity/p/23929/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">2fb9905b13e72e0f6751aef2810ea9bc</guid>
				<title>Torres Robinson posted an update: Cross-linked polyethylene (XLPE) has been recognized as an [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/22254/</link>
				<pubDate>Sat, 07 Jun 2025 10:59:07 -0400</pubDate>

									<content:encoded><![CDATA[<p>Cross-linked polyethylene (XLPE) has been recognized as an outstanding insulator for high-voltage power cables due to its favorable structural integrity at high temperature, low moisture sensitivity, chemical resistance, and low rates of failure due to aging. However, the roles of by-products and amorphous regions generated during the XLPE&hellip;<span class="activity-read-more" id="activity-read-more-22254"><a href="https://www.catswannabecats.com/activity/p/22254/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">0bc76ea05e36b7d1222425940bdb4753</guid>
				<title>Torres Robinson posted an update: Vergleichbarkeit zur Therapiebeurteilung von soliden Tumoren [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/20011/</link>
				<pubDate>Thu, 05 Jun 2025 10:59:10 -0400</pubDate>

									<content:encoded><![CDATA[<p>Vergleichbarkeit zur Therapiebeurteilung von soliden Tumoren nach RECIST hergestellt.. · Weitere Studien werden zeigen, welche der Klassifikationen in welchem Studiensetting am besten geeignet ist.. ZITIERWEISE · Skusa C, Weber M, Böttcher S et al. Criteria-Based Imaging and Response Evaluation of Lymphoma 20 Years After Cheson What is New?. Fort&hellip;<span class="activity-read-more" id="activity-read-more-20011"><a href="https://www.catswannabecats.com/activity/p/20011/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">9cf0b86f92a656d7e9ca187377c1b86b</guid>
				<title>Torres Robinson posted an update: Auricular arteriovenous malformation (AVM) occasionally [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/18861/</link>
				<pubDate>Wed, 04 Jun 2025 11:21:50 -0400</pubDate>

									<content:encoded><![CDATA[<p>Auricular arteriovenous malformation (AVM) occasionally accompanies macrotia. Here, the authors report a case of AVM with macrotia that was treated with transcatheter arterial embolization, percutaneous sclerotherapy, and subsequent otoplasty following partial resection. A 46-year-old man presented with Schobinger stage III AVM. After&hellip;<span class="activity-read-more" id="activity-read-more-18861"><a href="https://www.catswannabecats.com/activity/p/18861/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">85d2fccc9166751a58e28c88980c5d8b</guid>
				<title>Torres Robinson posted an update: 79 [0.70-0.90]. Selleck 3-Aminobenzamide However, we [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/4832/</link>
				<pubDate>Sat, 31 May 2025 14:11:08 -0400</pubDate>

									<content:encoded><![CDATA[<p>79 . <a href="https://www.selleckchem.com/products/3-aminobenzamide.html" rel="nofollow ugc">Selleck 3-Aminobenzamide</a> However, we observed no significant difference between 2 treatments in progression-free survival (hazard ratio  = 0.96 ). Furthermore, anti-PD1/PD-L1 monotherapy caused less treatment-related adverse events than standard of care.</p>
<p> Anti-PD1/PD-L1 monotherapy could indeed reduce the risk of death in R/M SCCHN&hellip;<span class="activity-read-more" id="activity-read-more-4832"><a href="https://www.catswannabecats.com/activity/p/4832/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">133eb910bb60d635a6d28ed64fdf8d6e</guid>
				<title>Torres Robinson became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/4737/</link>
				<pubDate>Sat, 31 May 2025 13:56:11 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>